| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Chimeric alphavirus vaccine candidates for chikungunya
|
Wang, Eryu
|
|
2008
|
26 |
39 |
p. 5030-5039
10 p.
|
article
|
| 2 |
Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity
|
Hamdy, Samar
|
|
2008
|
26 |
39 |
p. 5046-5057
12 p.
|
article
|
| 3 |
Editorial Board
|
|
|
2008
|
26 |
39 |
p. CO2-
1 p.
|
article
|
| 4 |
Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines
|
Xiao, Wenjun
|
|
2008
|
26 |
39 |
p. 5022-5029
8 p.
|
article
|
| 5 |
Evaluation of the pathogenicity of African Horsesickness (AHS) isolates in vaccinated animals
|
von Teichman, Beate F.
|
|
2008
|
26 |
39 |
p. 5014-5021
8 p.
|
article
|
| 6 |
Gene profiling analysis of ALVAC infected human monocyte derived dendritic cells
|
Harenberg, Anke
|
|
2008
|
26 |
39 |
p. 5004-5013
10 p.
|
article
|
| 7 |
Immunogenicity assay of the Leishmune® vaccine against canine visceral leishmaniasis in Brazil
|
Borja-Cabrera, G.P.
|
|
2008
|
26 |
39 |
p. 4991-4997
7 p.
|
article
|
| 8 |
Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes
|
Dai, Kaifan
|
|
2008
|
26 |
39 |
p. 5062-5071
10 p.
|
article
|
| 9 |
Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5–14 years old children
|
Esteghamati, Abdoulreza
|
|
2008
|
26 |
39 |
p. 5058-5061
4 p.
|
article
|
| 10 |
Report of the 4th meeting on the “Evaluation of pandemic influenza prototype vaccines in clinical trials”
|
Girard, Marc
|
|
2008
|
26 |
39 |
p. 4975-4977
3 p.
|
article
|
| 11 |
The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines
|
Thompson, Joseph M.
|
|
2008
|
26 |
39 |
p. 4998-5003
6 p.
|
article
|
| 12 |
The use of mycobacterial adjuvant-based agents for immunotherapy of cancer
|
Grange, J.M.
|
|
2008
|
26 |
39 |
p. 4984-4990
7 p.
|
article
|
| 13 |
Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis
|
Cuppari, Anahi Fernandez
|
|
2008
|
26 |
39 |
p. 5040-5045
6 p.
|
article
|
| 14 |
World wide experience with inactivated poliovirus vaccine
|
Bonnet, Marie-Claude
|
|
2008
|
26 |
39 |
p. 4978-4983
6 p.
|
article
|
Journal description